Furthermore, MAP2K1 (MEK1) gene expression was higher in AML cells with increased LGALS3 expression according to the “The Cancer Genome Atlas” (TCGA) database [64]. The gene discussed is MAP2K1; the disease is acute myeloid leukemia.